Gene editing techniques may eventually allow trisomy to be treated at the cellular level, according to an in vitro ...

Conventional human pluripotent stem cells at the primed pluripotent state are capable of generating all the embryonic ...

After implanting the scaffold just under the skin around the shoulder blades, the team induced the MS-like autoimmune condition in half of the mice while the other half served as a healthy comparison.

Australia's Magic Valley has received A$100,000 in government funding to scale up production and drive down costs of its cultivated meat.

Fate Therapeutics, Inc. (NASDAQ: FATE), a clinical-stage biopharmaceutical company dedicated to bringing a first-in-class ...

The global induced pluripotent stem cells market size is calculated at USD 2.13 billion in 2025 and is expected to reach ...

Extraembryonic trophoblast lineages constitute the placenta, and are essential for individual development. In human early embryo development, these cells can be generated from totipotent blastomeres.

Kenai Therapeutics, a biotechnology company leveraging induced pluripotent stem cell (iPSC) technology to discover and develop a platform of off-the-s ...

Scientists from the German Cancer Research Center (DKFZ) and ShanghaiTech University have developed an innovative method for ...